Biocom and McDermott, Will & Emery invite you to a Lunch & Learn and networking event on Thursday, November 1st.  The potential for personalized/precision medicine and Digital Health has been hyped for some time but has only recently gained traction as the technologies required have matured enough to be practically applied (e.g., Artificial Intelligence/Machine Learning, CRISPR, etc.) or become more affordable (i.e., whole genome sequencing) to the masses. It is estimated that the global personalized/precision marketplace will reach $141.7 billion by 2026.

Please join us for a presentation on how to develop defensible intellectual property protection for innovations in this space, including discussion of recent United States Supreme Court holdings that have made some categories of inventions (that are commonly found in personalized/precision medicine and digital health innovations) difficult to patent.